Search - tctmd.com

Displaying 621 - 640 of 1726

Sort: Relevancy | Date

Presentation TCT 2017

Statistical Comparison of the DANCE Trial 12-Month Outcomes of Adventitial Dexamethasone versus Comparator Drug-Coated Balloon Studies

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh

November 01, 2017

Presentation TCT 2017

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Piotr P. Buszman

November 01, 2017

Presentation TCT 2017

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Georgios Bouras

November 01, 2017

Presentation TCT 2017

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

Presenter: Emmanouil S. Brilakis, Christopher E. Buller, Pieter R. Stella

November 01, 2017

Presentation TCT 2017

The PLLA-Based Xinsorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Junbo Ge

October 31, 2017

Presentation TCT 2017

The Thin-Strut PLLA-Based Arteriosorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

Debate: EXCEL and NOBLE Prove That PCI Is Still Far From Being an Acceptable Alternative to CABG for Left Main Revascularization, With the Exception of a Small Proportion of Patients!

Presenter: Evald H. Christiansen, Erick Schampaert, John D. Puskas

October 31, 2017

Presentation TCT 2017

The RENUVIA PLLA-Based BRS Platform With Extended Drug Release

Presenter: Ron Waksman, Robert-Jan van Geuns, Sujith K Seneviratne

October 31, 2017

Presentation TCT 2017

The Thin-Strut PLLA-Based FIRESORB

Presenter: Ron Waksman, Robert-Jan van Geuns, Bo Xu

October 31, 2017

Presentation TCT 2017

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

Presenter: Evald H. Christiansen, Erick Schampaert, Marco V. Wainstein

October 31, 2017

Presentation TCT 2017

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

Left Main Case(s) #7: Rationale and Feasibility of Bioresorbable Scaffolds

Presenter: Kenneth Chin, Nicholas J. Lembo, Bernardo Cortese

October 31, 2017

Presentation TCT 2017

The Thin-Strut PLLA-Based MeRes100

Presenter: Ron Waksman, Robert-Jan van Geuns, Ashok Seth

October 31, 2017

Presentation TCT 2017

The Sirolimus-Eluting PLLA-Based Neovas Scaffold: Extended Results From the Randomized Trial

Presenter: Bernard R. Chevalier, Corrado Tamburino, Kai Xu

October 31, 2017

Presentation TCT 2017

Magmaris: Clinical and Imaging Results With Drug-Eluting Magnesium-Based Scaffolds

Presenter: Bernard R. Chevalier, Corrado Tamburino, Ron Waksman

October 31, 2017

Presentation TCT 2017

The Role of Left Main PCI After EXCEL and NOBLE

Presenter: Alaide Chieffo, Jonathan M. Hill, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Fortitude, Aptitude, and Magnitude: Progressively Thin-Strut BRS Based on Ultra-High Molecular Weight Amorphous PLLA

Presenter: Bernard R. Chevalier, Corrado Tamburino, Juan F. Granada

October 31, 2017

Presentation TCT 2017

Fantom: A Radio-Opaque Stent-Like BRS With Improved Expansion Characteristics

Presenter: Bernard R. Chevalier, Corrado Tamburino, James B. Hermiller Jr.

October 31, 2017

Presentation TCT 2017

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

Presenter: Bernard R. Chevalier, Corrado Tamburino, Stefan Verheye

October 31, 2017

Presentation TCT 2017

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

Presenter: Bernard R. Chevalier, Corrado Tamburino, Yoshinobu Onuma

October 31, 2017

Advertisement

Statistical Comparison of the DANCE Trial 12-Month Outcomes of Adventitial Dexamethasone versus Comparator Drug-Coated Balloon Studies

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

24-month Results From a First-In-Human Data on the Paclitaxel Drug Coated Chocolate Coronary PTCA Balloon Catheters in De-Novo Coronary Lesions

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 2-Year Clinical Follow-Up

The PLLA-Based Xinsorb

The Thin-Strut PLLA-Based Arteriosorb

Debate: EXCEL and NOBLE Prove That PCI Is Still Far From Being an Acceptable Alternative to CABG for Left Main Revascularization, With the Exception of a Small Proportion of Patients!

The RENUVIA PLLA-Based BRS Platform With Extended Drug Release

The Thin-Strut PLLA-Based FIRESORB

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

Left Main Case(s) #7: Rationale and Feasibility of Bioresorbable Scaffolds

The Thin-Strut PLLA-Based MeRes100

The Sirolimus-Eluting PLLA-Based Neovas Scaffold: Extended Results From the Randomized Trial

Magmaris: Clinical and Imaging Results With Drug-Eluting Magnesium-Based Scaffolds

The Role of Left Main PCI After EXCEL and NOBLE

Fortitude, Aptitude, and Magnitude: Progressively Thin-Strut BRS Based on Ultra-High Molecular Weight Amorphous PLLA

Fantom: A Radio-Opaque Stent-Like BRS With Improved Expansion Characteristics

Desolve Nx, Cx, and Amity: A Family of Progressively Thinner-Strut PLLA-Based BRS With Novel Properties

Do Some, All, or None of the Outcomes With the First Generation Absorb Scaffold Imply a Class Effect for All BRS? Educated Insights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content